Amarantus Bioscience Holdings Inc (AMBS)

[retiredtech]

Study Conclusion: "The results of this study together with the literature on MANF warrant a further development of this growth factor for the treatment of PD. While the path forward is facilitated by experience gained in the GDNF development, MANF, based on its different and unexploited mechanism of action, offers a promising new approach towards therapy of PD."

MANF probably is the ANSWER! Why this report was released so late is a REAL PROBLEM!